Inhaled 3% hypertonic saline shows promise for antibiotic-naïve NTM lung disease
Inhaled 3% hypertonic saline is associated with improved symptoms and microbiological stabilization in patients with antibiotic-naïve NTM-LD.
Indication
Clinical and regulatory intelligence for Nontuberculous Mycobacterial Lung Disease with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No related entities indexed yet.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.